Brain ILC2 Activation for Aging-Related Cognitive Decline
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The roles and regulation of immune cells, particularly tissue-resident lymphocytes, in maintaining cognitive function and combating neurodegenerative disorders such as Alzheimer's Disease, are poorly understood, and aging affects immune cell function and increases susceptibility to cognitive decline.
Innovation Solution
Implanting or activating group-2 innate lymphoid cells (ILC2) in the choroid plexus of the brain using activators like IL-33, IL-25, or IL-7 to enhance their activity, which produces cytokines that alleviate cognitive decline and reduce neuroinflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If tissue-resident lymphocytes are ignored or excluded from immune surveillance, then the brain is considered immune-privileged and protected from immune-related damage, but cognitive function deteriorates and neurodegenerative disorders progress
Solution Approach 1:
The patent changes the parameter of immune cell presence by introducing tissue-resident lymphocytes into the brain environment, transforming the immune system's role from absent to actively protective. This parameter change enables immune surveillance while maintaining cognitive function and reducing neuroinflammation through the action of these resident lymphocytes.
2Reliability
If adaptive immune cells are transferred to restore cognitive function, then cognitive impairment is improved, but the complexity of immune system regulation increases
Solution Approach 1:
The patent employs self-service by enabling tissue-resident lymphocytes to autonomously perform immune surveillance and cognitive protection functions within the brain. These lymphocytes self-regulate and act locally without requiring external adaptive immune cell transfer or complex systemic immune modulation, thereby improving cognitive function while avoiding increased regulatory complexity.
3Reliability
If circulating adaptive immune cells are used for immune surveillance, then cognitive protection is achieved, but the understanding of tissue-resident lymphocyte function remains insufficient
Solution Approach 1:
The patent extracts and isolates tissue-resident lymphocytes from the complex immune system, focusing specifically on their unique functions within the brain. By taking out these resident lymphocytes for study and application, the patent achieves cognitive protection while simultaneously filling knowledge gaps about their specific mechanisms of action, thereby reducing loss of information.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
ILC2 activation revitalizes the aged brain, reducing neuroinflammation and improving cognitive function by enhancing the production of IL-5 and IL-13, potentially offering therapeutic avenues for aging-related neurodegenerative disorders.
Implementation Method 1
ILC2 activation revitalizes the aged brain, reducing neuroinflammation and improving cognitive function by enhancing the production of IL-5 and IL-13
Data Source
AI summary
The present disclosure relates to a method of improving cognitive function in a subject. The method includes implanting group-2 innate lymphoid cells (ILC2) in a cranium of a subject, where the ILC2 was treated with an ILC2 activator. The present disclosure further relates to a method including selecting a subject having aging-associated cognitive decline and administering to the subject an activator of innate lymphoid cell activity under conditions effective to promote innate lymphoid cell activity. The present disclosure further relates to a method of improving cognition in a subject. The method includes selecting a subject having aging-associated cognitive decline and administering to the subject a cytokine selected from the group consisting of IL-33, IL-5, IL-7, IL-25, and thymic stromal lymphopoietin.